Clinical Trial: Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Neoplasms
Study Type: INTERVENTIONAL
Official Title: An Open-label, Multicenter Phase 1 Study to Characterize Safety, Tolerability, Preliminary Antitumor Activity and Pharmacokinetics of VIP236 Monotherapy in Subjects With Advanced Cancer
Brief Summary:
Determine the safety, tolerability, and maximum tolerated dose (MTD) of IV administered VIP236 as monotherapy in patients with advanced solid tumor cancer
Read more